“High cancer incidences together with rising household income in US states propel the adoption of personalized cancer whole genome sequencing”, says RNCOS research.
Noida, UP -- (SBWIRE) -- 07/21/2014 -- The explosion of whole genome sequencing method anticipate personalized cancer treatment through development of high end sequencing methods along with exponential decline in the cost of sequencing. A significant decline in the cost of whole genome sequencing is likely to generate a potential market of US$5.2 Billion in 2013. The potential for whole genome sequencing help the market players to gauge maximum opportunity for growth.
Rising population across United States, increasing cancer prevalence and affordability among the population generate a customer base of around 1 million who can easily afford personalized caner whole genome sequencing services. California is leading in terms of new cancer cases followed by several other states. In 2014, approximately 171, 730 new cancer cases are expected across the state. Beside the incidence rates, a rising trend has been observed in people earning more than 100,000 US$. Meanwhile, California is far ahead of other states in terms of household income with a total of 3,452,418 households earning US$ 100,000. Therefore, combination of high cancer incidences and high household income of the resident families indicates the opportunity areas for the industry’s players to widely adopt personalized cancer whole genome sequencing.
The report, “US Personalized Cancer Genome Sequencing Market Outlook 2018”, by RNCOS which is spread around 74 pages provides an in-depth research and rational analysis of the current status and expected Whole Genome Sequencing Market. Besides, it facilitates the current and potential of the Whole Genome Sequencing Market. Besides, the report prudently analyzed various factors such as cancer prevalence, incidence rates, and affordable states for WGS across United States. The report also covers the strengths and weaknesses of market players. A detailed study of regulatory insights has been covered in the report. Further, the report also illustrates the market restraints that impact the potential of Whole Genome Sequencing market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM672.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.